Johan Joly

1.2k total citations
53 papers, 555 citations indexed

About

Johan Joly is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Johan Joly has authored 53 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 18 papers in Hematology and 12 papers in Genetics. Recurrent topics in Johan Joly's work include Rheumatoid Arthritis Research and Therapies (43 papers), Autoimmune and Inflammatory Disorders Research (18 papers) and Systemic Lupus Erythematosus Research (14 papers). Johan Joly is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (43 papers), Autoimmune and Inflammatory Disorders Research (18 papers) and Systemic Lupus Erythematosus Research (14 papers). Johan Joly collaborates with scholars based in Belgium, Netherlands and United States. Johan Joly's co-authors include René Westhovens, Patrick Verschueren, Diederik De Cock, Kristien Van der Elst, Sofia Pazmiño, Veerle Stouten, Sabrina Meyfroidt, Delphine Bertrand, Francesca de Terlizzi and Christian Wüster and has published in prestigious journals such as Journal of Bone and Mineral Research, Annals of the Rheumatic Diseases and Bone.

In The Last Decade

Johan Joly

49 papers receiving 546 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Johan Joly 289 146 118 74 62 53 555
Ana Filipa Mourão 534 1.8× 36 0.2× 271 2.3× 67 0.9× 74 1.2× 58 983
Annette Szumski 896 3.1× 82 0.6× 349 3.0× 99 1.3× 122 2.0× 54 1.1k
Karel Ronday 449 1.6× 41 0.3× 304 2.6× 68 0.9× 30 0.5× 15 630
M.L. te Winkel 86 0.3× 199 1.4× 156 1.3× 30 0.4× 50 0.8× 25 764
G R Struthers 348 1.2× 46 0.3× 108 0.9× 65 0.9× 27 0.4× 27 734
Warren Raymond 233 0.8× 52 0.4× 32 0.3× 42 0.6× 17 0.3× 58 513
Lena Andersen 375 1.3× 26 0.2× 243 2.1× 50 0.7× 75 1.2× 21 587
Şebnem Ataman 263 0.9× 22 0.2× 109 0.9× 60 0.8× 15 0.2× 44 514
Raj Sengupta 930 3.2× 96 0.7× 347 2.9× 40 0.5× 12 0.2× 106 1.1k
Finbar O’Shea 719 2.5× 112 0.8× 389 3.3× 77 1.0× 12 0.2× 62 1.0k

Countries citing papers authored by Johan Joly

Since Specialization
Citations

This map shows the geographic impact of Johan Joly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Joly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Joly more than expected).

Fields of papers citing papers by Johan Joly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Joly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Joly. The network helps show where Johan Joly may publish in the future.

Co-authorship network of co-authors of Johan Joly

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Joly. A scholar is included among the top collaborators of Johan Joly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Joly. Johan Joly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michel, Laurent, Tiffany Charmet, Johan Joly, et al.. (2025). Diagnostic Performances of a Rapid Screening Tool for Detection of Psychiatric Symptomatology in an Urban Community Setting of People Who Use Drugs in France. Journal of Dual Diagnosis. 21(4). 280–295.
2.
3.
Bertrand, Delphine, et al.. (2024). A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial. Lara D. Veeken. 64(5). 2505–2514. 1 indexed citations
4.
Fadlallah, Sukayna, Pieter Ruytinx, Jori Liesenborgs, et al.. (2024). Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis. RMD Open. 10(4). e004743–e004743. 1 indexed citations
5.
Pazmiño, Sofia, René Westhovens, Veerle Stouten, et al.. (2023). POS0327 SPEED OF RESPONSE MATTERS: POST-HOC ANALYSIS OF PATIENTS WITH EARLY SERONEGATIVE RHEUMATOID ARTHRITIS INCLUDED IN THE CARERA TRIAL. Annals of the Rheumatic Diseases. 82. 409–410.
6.
Stouten, Veerle, Sofia Pazmiño, Delphine Bertrand, et al.. (2023). Patient–physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation. Lara D. Veeken. 64(2). 821–825. 2 indexed citations
7.
8.
Pazmiño, Sofia, Anikó Lovik, Annelies Boonen, et al.. (2022). New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis. Lara D. Veeken. 62(1). 108–115. 8 indexed citations
9.
Pazmiño, Sofia, Delphine Bertrand, Diederik De Cock, et al.. (2022). Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response. Annals of the Rheumatic Diseases. 81(10). 1385–1391. 9 indexed citations
10.
Bertrand, Delphine, Sofia Pazmiño, Diederik De Cock, et al.. (2022). Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial. Clinical Rheumatology. 42(1). 39–45. 2 indexed citations
11.
Stouten, Veerle, René Westhovens, Sofia Pazmiño, et al.. (2021). Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial. Annals of the Rheumatic Diseases. 80(8). 965–973. 21 indexed citations
12.
Elst, Kristien Van der, Patrick Verschueren, Diederik De Cock, et al.. (2020). One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment. RMD Open. 6(1). e001146–e001146. 24 indexed citations
13.
14.
Pazmiño, Sofia, Annelies Boonen, Veerle Stouten, et al.. (2020). Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial. Annals of the Rheumatic Diseases. 79(5). 556–565. 14 indexed citations
15.
Joly, Johan, Anne Carricajo, Paul O. Verhoeven, et al.. (2020). Strategy using a new antigenic test for rapid diagnosis of Streptococcus pneumoniae infection in respiratory samples from children consulting at hospital. BMC Microbiology. 20(1). 79–79. 2 indexed citations
16.
17.
Meyfroidt, Sabrina, Marlies Hulscher, Diederik De Cock, et al.. (2015). A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis. Clinical Rheumatology. 34(5). 861–869. 12 indexed citations
18.
Cock, Diederik De, René Westhovens, Johan Joly, et al.. (2014). Comparison of MTX Therapy with or without A Moderate Dose Glucocorticoid Bridging Scheme in Early Rheumatoid Arthritis Patients Lacking Classical Poor Prognostic Markers: Week 16 Results from the Randomized Multicenter Carera Trial. Annals of the Rheumatic Diseases. 73. 220. 2 indexed citations
19.
Meyfroidt, Sabrina, Diederik De Cock, Kristien Van der Elst, et al.. (2014). Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis. Scandinavian Journal of Rheumatology. 43(4). 265–272. 13 indexed citations
20.
Westhovens, René, Frédéric Houssiau, Johan Joly, et al.. (2006). A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 33(5). 847–53. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Filipa Mourão Breakdown of academic impact, for papers by Annette Szumski Breakdown of academic impact, for papers by Karel Ronday Breakdown of academic impact, for papers by M.L. te Winkel Breakdown of academic impact, for papers by G R Struthers Breakdown of academic impact, for papers by Warren Raymond Breakdown of academic impact, for papers by Lena Andersen Breakdown of academic impact, for papers by Şebnem Ataman Breakdown of academic impact, for papers by Raj Sengupta Breakdown of academic impact, for papers by Finbar O’Shea
Rankless by CCL
2026